Pluri (PLUR) Goodwill & Intangibles (2025)

Pluri (PLUR) reported Goodwill & Intangibles of $5.8 million for Q4 2025, down 0.76% quarter-over-quarter from $5.9 million in Q3 2025.

Pluri (PLUR) Goodwill & Intangibles (2025) Analysis & Trends

Pluri (PLUR) has 1 years of Goodwill & Intangibles data on file, last reported at $5.8 million in Q4 2025.

Goodwill & Intangibles for Q4 2025 came in at $5.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $5.8 million (changed N/A YoY), and the FY2025 annual result was $5.9 million, changed N/A from the prior year.
Goodwill & Intangibles eased to $5.8 million in Q4 2025 per PLUR's latest filing, from $5.9 million in the prior quarter.
Over five years, Goodwill & Intangibles peaked at $5.9 million in Q2 2025 and troughed at $5.8 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	Pluri	21.39 Mn	21.87 Mn	86,000.00

Download Data